CYP2C19 y acontecimientos adversos pediátricos durante el tratamiento con citalopram, escitalopram y sertralina

CYP2C19 and Pediatric Adverse Events During Citalopram, Escitalopram and Sertraline Treatment

Titulo Original: CYP2C19 and Pediatric Adverse Events During Citalopram, Escitalopram and Sertraline Treatment
Productora : American Academy of Pediatrics
Pais: United States
Ano: 2020
Duración: 4
Género: Medical documentary
Color: Color
Idioma original: Ingles
Idiomas disponibles: English

Sinopsis:

This retrospective cohort study demonstrates that extrapolation of adult pharmacogenetic guidelines for sertraline, escitalopram, and citalopram and CYP2C19 is not appropriate for pediatric patients.